Anders Grubb
191 – 200 of 350
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1999
-
Mark
Cystatin C deficiency in human atherosclerosis and aortic aneurysms
(
- Contribution to journal › Article
-
Mark
Urine IgG2/IgG4-ratio indicates the significance of the charge selective properties of the glomerular capillary wall for the macromolecular transport in glomerular diseases
1999) In Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 14(6). p.1425-1429(
- Contribution to journal › Article
- 1998
-
Mark
Cystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitor
(
- Contribution to journal › Article
-
Mark
Structural basis for different inhibitory specificities of human cystatins C and D
(
- Contribution to journal › Article
-
Mark
Intracellular accumulation of the amyloidogenic L68Q variant of human cystatin C in NIH/3T3 cells
(
- Contribution to journal › Article
-
Mark
Cystatin D, a natural salivary cysteine protease inhibitor, inhibits coronavirus replication at its physiologic concentration
(
- Contribution to journal › Article
-
Mark
In vivo XRF as a means to evaluate the risk of kidney effects in lead and cadmium exposed smelter workers
(
- Contribution to journal › Article
-
Mark
Serum cystatin C as a determinant of glomerular filtration rate in children
(
- Contribution to journal › Article
-
Mark
Screening for weak monoclonal antibodies in hybridoma technology
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Affinity screening for weak monoclonal antibodies
(
- Contribution to journal › Article